• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON & JOHNSON VISION CARE, INC. ¿ IRELAND 1-DAY ACUVUE TRUEYE (NARA A); LENSES, SOFT CONTACT, DAILY WEAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON & JOHNSON VISION CARE, INC. ¿ IRELAND 1-DAY ACUVUE TRUEYE (NARA A); LENSES, SOFT CONTACT, DAILY WEAR Back to Search Results
Catalog Number 1D4
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Erosion (1750); Corneal Ulcer (1796); Pain (1994); Red Eye(s) (2038)
Event Date 09/28/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).Initial reporter's phone number: (b)(6).
 
Event Description
On (b)(6) 2018 a representative from an eye care provider¿s (ecp) office in (b)(6) called to report a patient (pt) had redness and pain os on insertion of a 1-day acuvue® trueye® brand contact lens on (b)(6) 2018.The symptoms persisted on removal of the suspect lens.The pt presented to the ecp¿s office on (b)(6) 2018 and was diagnosed with a corneal ulcer and erosion os.The pt was instructed to discontinue contact lens wear until the symptoms resolve and pt is to return to clinic.Pt was prescribed ofloxacin gel forming "ophtheamic" solution, odomel ophthalmic suspension and erycoli ophthalmic ointment.The pt returned to the ecp office for follow-up on (b)(6) 2018 and (b)(6) 2018.No further instructions for follow-up were given to the pt.The representative reported redness and os pain are persisting.No additional medical information was provided.On 22oct2018 a call was placed to the pts treating ecp and additional medical information was requested.No additional medical information was provided.On 29oct2018 a call was placed to the pts treating ecp and additional medical information was requested, but nothing additional was received.A lot history review was performed and revealed the following: the batch record did not show any abnormalities in monomer and solution testing.All parameters tested were within specification.All sterilization requirements were successfully completed.Lot 5257140108 was produced under normal conditions.The suspect lens was discarded.If any further relevant information is received, a supplemental report will be filed.Serious reportable event trends are reviewed quarterly in franchise management review meetings.
 
Manufacturer Narrative
On 12nov2018, additional information was received in a written report from the treating eye care professional (ecp): the patient (pt) presented to the clinic complaining of pain and redness in the left eye (os).¿diagnosis: corneal ulcer os; ¿infectiveness: admitted¿; culture performed (unspecified results); ¿focal site: off pupil, superior part of os at 12 o¿clock position; treatment: ofloxacin gel forming ophthalmic solution, tobracin ophthalmic solution and ecolicin ophthalmic ointment¿; pt was instructed to discontinue contact lens (cl) wear.The pt returned to the clinic on (b)(6) 2018; ¿outcome: back on the recovery track was noted¿; pt was instructed to discontinue cl wear.The pt returned to the clinic on (b)(6) 018; ¿va: os 1.2; pt was instructed to discontinue cl wear; pt was instructed to return to the clinic but did not return.¿seriousness: not serious; causal relationship with cl: cannot be denied as the event occurred while the pt was wearing cl; outcome: improved.¿ on 21nov2018, additional information was received the treating ecp clinic: a representative reported that the pt has not returned to the clinic since (b)(6) 2018.No additional information has been received.If any further relevant information is received, a supplemental report will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
1-DAY ACUVUE TRUEYE (NARA A)
Type of Device
LENSES, SOFT CONTACT, DAILY WEAR
Manufacturer (Section D)
JOHNSON & JOHNSON VISION CARE, INC. ¿ IRELAND
one technological park plassey
limerick
EI 
MDR Report Key8056725
MDR Text Key126907735
Report Number9617710-2018-05066
Device Sequence Number1
Product Code LPL
Combination Product (y/n)Y
PMA/PMN Number
K073485
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign,health profe
Type of Report Initial,Followup
Report Date 11/12/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date04/01/2023
Device Catalogue Number1D4
Device Lot Number5257140108
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/19/2018
Initial Date FDA Received11/09/2018
Supplement Dates Manufacturer Received11/12/2018
Supplement Dates FDA Received12/06/2018
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age44 YR
-
-